Skip to main content
. Author manuscript; available in PMC: 2024 Mar 13.
Published in final edited form as: Br J Haematol. 2021 Nov 14;196(2):380–389. doi: 10.1111/bjh.17920

Table III.

Transfusion and iron overload: transfusion, chelation, and iron assessment.

Transfusion, chelation and iron assessment Age 18·39
Age ≥40
Chi-square P values
No. % No. %
Transfusion status 0·947
 Chronically transfused 163 81 64 85
 Intermittently transfused   3   1·5  1   1·3
 Non-transfused  26  13  9  12
Ever received regular chelation therapy 0·06
 No  23  11  3   4
 Yes 178  89 72  96
Currently received regular chelation therapy 0·04
 No  43  21  8  11
 Yes 158  79 67  89
Chelation therapy currently 0·02
 Combination  52  26 10  13
 Deferasirox  85  42 41  55
 Deferiprone   4   2  4   5·3
 Deferoxamine  17   8·5 12  16
 None  43  21  8  11
Ever had a liver iron measurement 0·16
 No  14   7  2   2·7
 Unknown   8   4  1   1·3
 Yes 179  89 72  96
Most recent method of liver iron measurement* 0·58
 Biopsy   3   1·5  0   0
 MRI 126  63 46  61
 SQUID  17   8·5  6   8
Total 201 100 75 100

MRI, magnetic resonance imaging; SQUID, Superconducting Quantum Interfering Device.

*

Liver iron content (mg iron per gram liver dry weight) measured by MRI (n = 126) and by liver biopsy (n = 3; one liver biopsy result not available for analysis) in n = 128 younger adults and by MRI in n = 46 older adults.

Liver iron content wet weight measured by SQUID in n = 7 younger adults and n = 6 older adults.